A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results
Okonogi, Noriyuki, Murata, Kazutoshi, Yamada, Shigeru, Habu, Yuji, Hori, Makoto, Kurokawa, Tomoya, Inaba, Yosuke, Fujiwara, Tadami, Fujii, Yasuhisa, Hanawa, Michiko, Kawasaki, Yohei, Hattori, Yoko, Suzuki, Kazuko, Tsuyuki, Kyoko, Wakatsuki, Masaru, Koto, Masashi, Hasegawa, Sumitaka, Ishikawa, Hitoshi, Hanaoka, Hideki, Shozu, Makio, Tsuji, Hiroshi, Usui, Hirokazu
Published in International journal of molecular sciences (23.06.2023)
Published in International journal of molecular sciences (23.06.2023)
Get full text
Journal Article
Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study
Okonogi, Noriyuki, Usui, Hirokazu, Murata, Kazutoshi, Hori, Makoto, Kurokawa, Tomoya, Fujiwara, Tadami, Fujii, Yasuhisa, Hanawa, Michiko, Kawasaki, Yohei, Hattori, Yoko, Suzuki, Kazuko, Tsuyuki, Kyoko, Wakatsuki, Masaru, Hasegawa, Sumitaka, Yamada, Shigeru, Hanaoka, Hideki, Shozu, Makio, Tsuji, Hiroshi
Published in BMJ open (01.03.2022)
Published in BMJ open (01.03.2022)
Get full text
Journal Article
A Phase Ib Study of Durvalumab : The Early Safety and Efficacy Results
Okonogi, Noriyuki, Murata, Kazutoshi, Yamada, Shigeru, Habu, Yuji, Hori, Makoto, Kurokawa, Tomoya, Inaba, Yosuke, Fujiwara, Tadami, Fujii, Yasuhisa, Hanawa, Michiko, Kawasaki, Yohei, Hattori, Yoko, Suzuki, Kazuko, Tsuyuki, Kyoko, Wakatsuki, Masaru, Koto, Masashi, Hasegawa, Sumitaka, Ishikawa, Hitoshi, Hanaoka, Hideki, Shozu, Makio, Tsuji, Hiroshi, Usui, Hirokazu
Published in International journal of molecular sciences (01.06.2023)
Published in International journal of molecular sciences (01.06.2023)
Get full text
Journal Article